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Abstract
Background: Prostate cancer is the most common cancer among men in Western countries but the exact
pathogenic mechanism of the disease is still largely unknown. An infectious etiology and infection-induced
inflammation has been suggested to play a role in prostate carcinogenesis and Propionibacterium acnes has been
reported as the most prevalent microorganism in prostatic tissue. We investigated the frequency and types of
P. acnes isolated from prostate tissue samples from men with prostate cancer and from control patients without
the disease.
Methods: We included 100 cases and 50 controls in this study. Cases were men diagnosed with prostate cancer
undergoing radical prostatectomy and controls were men undergoing surgery for bladder cancer without any
histological findings of prostate cancer. Six biopsies taken from each patient’s prostate gland at the time of surgery
were used for cultivation and further characterization of P. acnes.
Results: The results revealed that P. acnes was more common in men with prostate carcinoma than in controls,
with the bacteria cultured in 60 % of the cases vs. 26 % of the controls (p = 0.001). In multivariable analyses, men
with P. acnes had a 4-fold increase in odds of a prostate cancer diagnosis after adjustment for age, calendar year of
surgery and smoking status (OR: 4.46; 95 % CI: 1.93–11.26). To further support the biologic plausibility for a P. acnes
infection as a contributing factor in prostate cancer development, we subsequently conducted cell-based
experiments. P. acnes- isolates were co-cultured with the prostate cell line PNT1A. An increased cell proliferation
and cytokine/chemokine secretion in infected cells was observed.
Conclusion: The present study provides further evidence for a role of P. acnes in prostate cancer development.
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Background
Prostate cancer (PCa) is the most common malignant
neoplasm among men in Western industrialized coun-
tries and the second most common cancer diagnosed
among men worldwide [1, 2]. The exact pathogenic
mechanism of the disease is still largely unknown. How-
ever, chronic inflammation has been hypothesized to
affect prostate carcinogenesis [3]. Both chronic and
acute inflammation are commonly observed upon exam-
ination of histological samples [4]. This inflammation is
present throughout the entire gland, not only in close
proximity to the tumor, and thus is unlikely to be ex-
plained entirely as an immune response to malignancy
[5]. The multiple foci of inflammation observed are sug-
gestive of an infectious etiology and infection-induced
inflammation has been hypothesized to play a role in
prostate carcinogenesis [6].
Propionibacterium acnes is a Gram-positive bacillus
that forms part of the normal flora of the skin. Although
generally regarded as exhibiting low pathogenic poten-
tial, P. acnes has been recognized as contributing to the
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pathogenesis of acne vulgaris [7]. An increasing number
of reports have implicated the microorganism as an op-
portunistic pathogen responsible for a wide range of
low-grade infections such as orthopaedic implant device
related infections [8], prosthetic valve endocarditis [9],
sternal wound infections after cardiothoracic surgery
[10, 11], and shunt-associated central nervous system
infections [12]. Several independent studies have re-
cently reported a high frequency of P. acnes in pros-
tate tissue samples, both from men with prostatitis
and PCa [13–17]. Moreover, isolation of P. acnes has
been positively associated with the presence and extent of
both acute and chronic inflammation [14]. In addition,
previous studies have shown that P. acnes has the capabil-
ity to stimulate prostate epithelial cell lines to secret cyto-
kines and chemokines, such as Interleukin 6 (IL-6) and
Chemokine (C-X-C motif) ligand 8 (IL-8) [15, 18, 19].
These inflammatory markers are critical for a sustained
inflammatory response and both are thought to play an
important role in the development of different types of
cancers, among them PCa [20, 21]. Furthermore, two
different in vivo models have recently been developed sup-
porting the hypothesis of P. acnes as a contributing agent
for prostatic inflammation [22, 23].
Further evidence supporting the hypothesis of P. acnes
as a contributing factor in PCa development was pub-
lished by Fassi Fehri et al., showing transformation of
prostate cells after being infected with P. acnes [15], and
from epidemiologic studies showing that men treated
with tetracycline, commonly indicated for acne, were
more likely to be subsequently diagnosed with prostate
cancer [24].
The contradiction between the role as a skin com-
mensal and the more pathogenic behavior might be
partly explained by strain-specific properties where dif-
ferent P. acnes strains contribute differently to health
and disease.
P. acnes strains can be divided into the major types
IA, IB, II, and III according to sequence comparison of
the recA or tly genes [25]. More recently, further dis-
crimination has been aided by various multilocus se-
quence typing (MLST) schemes and repetitive-sequence-
based PCR protocols [26–29]. P. acnes subtype I, more
specifically termed I-1a, is predominantly associated
with moderate to severe acne [27, 28]. In contrast P.
acnes type II is reported as the most prevalent type in
previous studies of prostatic specimens obtained from
patients with PCa [14]. However, a major limitation in
studies performed to investigate the association between
P. acnes and PCa has been the lack of appropriate con-
trol tissue i.e. samples from men without prostate
malignancy.
In the present study we investigate the presence and types
of P. acnes strains isolated from multiple peri-operative
prostate tissue samples from men with PCa and from con-
trol patients with no histological evidence of the disease.
P. acnes was more in men with prostate cancer then in
controls, with the bacteria cultured in 60 % of the cases
vs. 26 % of the controls. To explore how P. acnes might
contribute to an increased risk for PCa initiation, we fur-
ther investigated the capacity of P. acnes to modulate pro-
liferation and secretion of inflammatory mediators in
prostate cells. The results showed an increased prolifera-
tion and cytokine/chemokine secretion in prostate cells
infected with P. acnes.
Results
Isolation of P. acnes from prostate tissue samples
Multiple prostate tissue samples were collected from
100 cases and 87 controls. However, 37 patients those
initially was categorized as controls displayed signs of
PCa at the pathological anatomical examination and
were subsequently considered as a separate group (con-
trols with PCa). Clinical characteristics for all cases and
controls without PCa are shown in Table 1.
The predominant microorganism obtained from the
prostatic tissue was P. acnes. Less frequent isolates in-
cluded coagulase negative staphylococcus and only sin-
gle isolates of other species such as Corynebacterium
species and Streptococcus species, similar to previous
studies [16, 29]. From the entire cohort, 182 bacterial
isolates were characterized as P. acnes. The bacteria
were identified in 60 % of the cases (60/100), a signifi-
cantly greater proportion compared to controls (13/50;
26 %) (p = 0.001). In controls with PCa, P. acnes was
found in 13/37 (35 %). In cases, there was no association
between P. acnes status and tumor stage (p = 0.43).
Median PSA levels at diagnosis were similar in P. acnes-
positive and P. acnes-negative cases (6.75 vs. 6.0 ng/mL,
respectively; p = 0.54). Cases had Gleason scores reflect-
ing more poorly differentiated tumors compared to con-
trols incidentally found to have tumor (Table 1; p <
0.0001). Among all cases and controls with incidental
tumor, there was no association between Gleason score
and P. acnes status.
As shown in Table 2, in a univariate logistic regression
model, men with P. acnes had a statistically significant
more than 4-fold increase in odds of PCa compared to
men without the bacterium. The association remained
statistically significant and became more pronounced
after adjustment for age at surgery, year of surgery and
smoking status (OR: 4.46; 95 % CI: 1.93–11.26).
To investigate the distribution of P. acnes in prostate
tissue, 6 biopsies were taken from each patient according
to a specific scheme (Fig. 1). In men with PCa, P. acnes
was identified in 134 biopsies, representing a median of
2 isolates per person (134/60). In controls P. acnes was
identified in 19 biopsies, equivalent to a median number
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of 1 isolate per person (19/13). The corresponding num-
bers for the controls with PCa were 29 positive biopsies
representing a median of 2 isolates per person (29/13).
Cases had a significantly higher number of P. acnes posi-
tive biopsies compared to the controls (p = 0.01). Fur-
thermore, a significant difference in the number of
positive biopsies was also found between the controls
and the controls with PCa (p = 0.04).
We also investigated the distribution of P. acnes in dif-
ferent prostate zones were the locations within zones
were estimated based on gross examination. Biopsy 1
and 2 represented the transition zone, 3 and 4 the per-
ipheral zone, and 5 and 6 the apex area (from Fig. 1). In
cases isolates appeared to be more evenly distributed
anatomically compared to the controls where infection
was more likely to be present in the transition zone,
even though not statistically significant (p = 0.07). The
results are presented in Table 3.
Typing based on tly
The different subtypes of the P. acnes isolates were in-
vestigated by amplifying and sequencing the putative he-
molysin gene tly, which was successfully performed in
all 182 isolates. P. acnes type I and II were the most
common lineages, detected at a similar ratio in both
cases and controls (Additional file 1). In controls with
prostate cancer, P. acnes type I was the most frequent
lineage. We further investigated whether a single pros-
tate gland could be infected with multiple P. acnes tly
types. Among patients with more than one biopsy posi-
tive for P. acnes, two different types were present in ap-
proximately 50 % (21/41).
Typing based on DiversiLab
The 182 prostatic P. acnes isolates could successfully be
typed by using the repetitive-sequence-based PCR
method (DiversiLab). Based on a minimum of 95 % simi-
larity and with a difference of up to one band in the den-
drogram, typing separated the prostatic isolates into the
three major tly types (I, II, and III) with only a few ex-
ceptions. The method differentiated the isolates into a
total number of 23 rep-PCR fingerprint patterns (Fpp)
shown in Additional file 1, where the most common
Fpp:s were 1, 2, 3, 6, 9, and 11 containing 13, 53, 12, 22,
17, and 11 P. acnes isolates respectively.
Wound-healing and proliferation assays
Wound-healing assays were performed in order to inves-
tigate if an infection with P. acnes type IA or II could
have an effect on the migration or proliferation of pros-
tate epithelial cells. The results indicated that cells in-
fected with P. acnes type IA or II closed the wound
Table 1 Selected characteristics of men with and without prostate cancer
Cases Controls P-value Controls with PCaa
N = 100 N = 50 N = 37
Age at surgery (yrs), Mean (STD) 64.0 (4.4) 65.7 (7.1) <0.0001 70.2 (2.1)
Year of surgery, Median (Min-Max) 2010 (2008–2011) 2011 (2009–2015) 0.002 2013 (2009–2015)
History of smoking, N (%) 8 (8.3) 7 (14.6) 0.24
P. acnes present, N (%) 60 (60.0) 13 (26.0) <0.0001 13 (35.1)
Surgical Gleason Score, N (%) – –
2-5 0 (0.0) 4 (5.8)
6 34 (34.0) 28 (75.7)
7 60 (60.0) 4 (10.8)
8-9 6 (6.0) 1 (2.7)
pTNM stage, N (%) – –
2 85 (85.9) –
3 14 (14.1) –
aCompared to cases, Chi-square p-value for P. acnes present = 0.01 and Mantel-Haenszel Chi-Square p-value for surgical Gleason score < 0.0001
Table 2 Odds ratios (95 % confidence intervals) for prostate cancer according to P. acnes in prostate tissue
Crude Model Model 1 Model 2a
P. acnes 4.27 (2.02–9.02) 3.66 (1.61–8.30) 4.67 (1.93–11.26)
Age at surgery, yrs (continuous) – 0.95 (0.88–1.02) 0.91 (0.84–0.99)
Year of surgery (continuous) – 0.48 (0.33–0.68) 0.46 (0.31–0.67)
Smoker – – 0.59 (0.15–2.34)
a5 subjects missing data on smoking excluded from analysis
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faster compared to uninfected cells. If the infected cells
were treated with Mitomycin C, this effect was not seen,
which indicates that a P. acnes infection in prostate epi-
thelial cells have an effect on proliferation, not migra-
tion. In order to quantitate potential differences in
proliferation between infected and uninfected cells, as
well as between different MOI of P. acnes, a proliferation
assay was used. PNT1A had an increased proliferation
when infected with P. acnes type IA or II for 24–48 h
(Table 4). However, none of the differences in prolifera-
tion were statistically significant.
Short-term infections
In order to investigate if an infection with P. acnes type IA
or II could modulate the secretion of pro-inflammatory
mediators from prostate cells, the concentrations of IL6
and CXCL8 were measured in cell-media from cells in-
fected with P. acnes and compared to uninfected cells.
When infecting PNT1A cells with P. acnes type IA or II at
different MOI for 48 h, a dose response effect could be
seen for the secretion of both IL-6 and CXCL8, with an
increasing secretion with increasing MOI (Fig. 2). There
were a statistically significant difference in the secretion of
IL-6 between uninfected cells and cells infected with 50
MOI of P. acnes type IA or II (p = 0.035, Fig. 2a and b).
There were also a statistically significant difference in the
secretion of CXCL8 between uninfected cells and cells in-
fected with 50 MOI of P. acnes type II (p = 0.01, Fig. 2d).
Long-term infections
The time-dependent differences in secretion of IL-6 and
CXCL8 after a P. acnes infection were also investigated.
PNT1A cells infected with P. acnes type IA or II for
48 h had a higher secretion of IL-6 compared to cells in-
fected for 1 week (Fig. 3a-b), although the opposite was
seen for CXCL8, where cells infected for 48 h had a
lower secretion compared to cells infected for 1 week
(Fig. 3c-d). These differences were not statistically sig-
nificant, although a marginally significant trend could be
seen for the CXCL8 secretion from cells infected with
P. acnes type IA (p = 0.055, after adjustments for multiple
testing).
Discussion
In the present study we investigated the presence of P.
acnes in a case–control study utilizing prostatic tissue
obtained from 100 men with PCa and 50 men with no
histological signs of the disease. This study design makes
the present study the first to our knowledge to simultan-
eously investigate the prevalence of P. acnes in the pros-
tate glands in men with and without histological
evidence of PCa. The results indicated that P. acnes was
more common in men with prostate carcinoma than in
healthy men, with P. acnes cultured in 60 % of the cases
vs. 26 % of the controls (p = 0.001). After controlling for
age, calendar time and smoking status, presence of P.
acnes in the prostate was associated with a 4.7 times
greater odds of a prostate cancer diagnosis. It was fur-
thermore interesting that among controls found to have
tumors, we isolated P. acnes from 35 %, an intermediate
proportion, providing evidence for P. acnes contributing
Fig. 1 Zonal anatomy of the prostate. Zonal anatomy of the human
prostate, divided into three glandular zones: central zone (CZ),
peripheral zone (PZ) and transition zone (TZ). The arrows indicate
were the 6 biopsies are taken
Table 3 Presence and distribution of P. acnes in cases, controls,
and controls with prostate cancer (PCa)
Cases Controls Controls with PCa
N = 100 N = 50 N = 37
P. acnes present 60 (60 %) 13 (26 %) 13(35 %)
P. acnes present in
Biopsy I 27 (20 %) 4 (21 %) 3 (10 %)
Biopsy II 21 (16 %) 4 (21 %) 4 (14 %)
Biopsy III 20 (15 %) 3 (16 %) 6 (21 %)
Biopsy IV 24 (18 %) 4 (21 %) 6 (21 %)
Biopsy V 25 (18 %) 3 (16 %) 5 (17 %)
Biopsy VI 17 (13 %) 1 (5 %) 5 (17 %)
Table 4 The percentage difference in proliferation seen in
PNT1A cells infected with P. acnes type IA or II for 24 – 48 h,
compared to uninfected cells
Time of infection MOI Type IA difference (%) Type II difference (%)
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not only to PCa detection but to risk of the disease per
se. Moreover, P. acnes was not related to PSA level,
tumor stage, or tumor grade. If P. acnes was only facili-
tating detection, we would expect it to be a marker of
more indolent tumors diagnosed at an earlier stage. The
prevalence of P. acnes in the cystoprostatectomy speci-
mens with prostate cancer was statistically significantly
lower than in radical prostatectomy specimens (p =
0.01). This result is consistent with P. acnes being intro-
duced into the prostate during trans-rectal biopsy in
some of the cases, but nonetheless being more frequent
in men with undiagnosed PCa than without detectable
cancer.
In the present study, we made an effort to minimize
the risk of P. acnes contamination during tissue sam-
pling and processing in a laboratory setting. Sterile,
single-use biopsy needles were used and the tissue cores
were obtained in the operating theatre immediately after
removal of the prostate. Given that all the samples were
handled in the same manner we believe that if our re-
sults were influenced by exogenous P. acnes it would
have similar influence on both cases and controls.
Furthermore, the presence of P. acnes in the prostate
cannot simply be explained by contamination due to bi-
opsies taken at diagnosis, since no trans-rectal biopsies
were performed within the controls or controls found to
have undiagnosed PCa.
In PCa, both culture and molecular techniques have
been used to evaluate the presence of P. acnes. In 2005,
Cohen et al. reported P. acnes as the most common
microorganism (35 %) in prostate tissue obtained from
men with PCa [14]. Alexeyev et al., reported that 50 %
of radical prostatectomy specimens were positive for P.
acnes when using fluorescence in situ hybridization [13].
In addition, Sfanos et al. performed a comprehensive
study evaluating prostatic P. acnes infection by applying
bacterial culture, 16 s rDNA cloning and, organism-
specific PCR. Here, P. acnes was the most commonly
cultured species (17 %) [16]. The disparity between the
studies may be related to use of unequal tissue collection
and bacterial detection methods.
Because strain-specific properties may contribute dif-
ferently to pathogenesis, we genotyped all the bacteria
isolates verified as P. acnes. In line with previous studies,
Fig. 2 Secretion of IL-6 and CXCL8 from PNT1A cells infected with P. acnes. Secretion of IL-6 and CXCL8 from PNT1A cells infected with P. acnes
type IA or II at different MOI. a IL-6 secretion from cells infected with P. acnes type I for 48 h. b IL-6 secretion from cells infected with P. acnes
type II for 48 h. c CXCL8 secretion from cells infected with P. acnes type I for 48 h. d CXCL8 secretion from cells infected with P. acnes type II for
48 h. * Statistical significant difference in secretion compared to uninfected cells (p < 0.05 after adjustments for multiple testing)
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P. acnes type II was the most common type in prostatic
tissue in our study, both in cases (51 %) and controls
(58 %), when using either repetitive-sequence-based
PCR or tly sequencing for discrimination. However, the
genotyping analyses also revealed the same proportion
of P. acnes classified as type IA or IB, 42 %, in both cases
and controls. These findings suggest that both P. acnes
types I and II have the capability to colonize the prostate
and potentially give rise to a chronic inflammation, a po-
tential risk factor for PCa.
Secretion of cytokines and chemokines, such as IL-6
and IL-8, are of significance for a sustained inflamma-
tory response; these mediators have also been suggested
to play an important role in the development of different
types of cancers, among them PCa. Therefore, we per-
formed cell-based experiments to investigate if an infec-
tion with P. acnes affects the secretion of IL-6 and IL-8
from premalignant prostate cell. The cell line PNT1A
was infected with two of the P. acnes isolates collected
from men with PCa in the present study, one type IA
and one type II. The results showed that both P. acnes
types have the capacity to modulate the secretion of IL-6
and IL-8, already at relatively low MOI. These data are
supported by previous work performed by Drott et al.
and Fassi Fehri et al., who observed an increased secre-
tion of both IL-6 and IL-8 from the premalignant pros-
tate cell line RWPE1 when infected with P. acnes type I
[15, 18]. In the present study we have only focused on
the secretion of two inflammatory mediators but previ-
ous reports have shown that P. acnes is an inducer of in-
flammatory factors such as caspase-1 and reactive
oxygen species, giving further support to the suggestion
that a sustained P. acnes infection may contribute to in-
flammation related PCa initiation. In line with previous
studies we also found a dose response effect between a
P. acnes infection at different MOI and IL-6/IL-8 secre-
tion. Based on these results, one could speculate that
even though a greater number of the bacterium would
considerably increase the secreted levels of IL-6 and IL-
8, an infection with a smaller number of P. acnes may
over time be enough to contribute to a micro milieu rich
in tumor supporting mediators. These findings can be of
importance since P. acnes predominantly was cultivated
from only two out of six biopsies from each patient.
P. acnes may contribute to prostate tumor initiation by
mechanisms other than stimulation of inflammatory me-
diators. In a recent in vitro study experiments revealed
that exposure to P. acnes altered cell proliferation and
Fig. 3 Secretion of IL-6 and CXC8 secretion between short and long-term infection. Differences in IL-6 and CXCL8 secretion between short- (48 h) and
long-term (1 week) infections of PNT1A cells infected with P. acnes type IA or II. a IL-6 secretion from cells infected with P. acnes type I for 48 h or
1 week. b IL-6 secretion from cells infected with P. acnes type II for 48 h or 1 week. c CXCL8 secretion from cells infected with P. acnes type I for 48 h
or 1 week. d CXCL8 secretion from cells infected with P. acnes type II for 48 h or 1 week
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enabled anchorage-independent growth in infected pros-
tate cells [15]. In the present study we performed wound
healing assays to determine differences in cell motility
after infection with P. acnes type IA and type II. PNT1A
cells infected with either type closed the wound faster
compared to untreated cells. This effect could not be
seen in cells pretreated with Mitomycin C, indicating
that P. acnes-induced proliferation was the responsible
cause rather than increased migration. We believe that
even though no statistically significant differences in
proliferation was found between infected and uninfected
cells in this study, a long-lasting small increase could po-
tentially have an biological impact on prostate cells.
A major strength in the present study was the inclu-
sion of prostatic tissue from men without any histo-
logical signs of PCa, addressing a significant limitation
in previous investigations. Approximately 40 % of the
initial controls showed evidence of PCa, highlighting the
challenge of identifying ideal control material with total
absence of prostate tumor. Our study also benefitted
from a reverse translational approach in which we
followed up on the initial epidemiologic findings with
basic science approaches to offer more insight into bio-
logic plausibility and underlying mechanisms. Our case–
control design did not, however, permit us to ascertain
temporality of P. acnes infection with respect to PCa.
Future studies should also address whether PCa initi-
ation could depend on the expression of different viru-
lence genes in P. acnes types present in the prostate
gland. Recently, Kasimatis et al. reported that a P. acnes
strain, associated with acne vulgaris, harbors a plasmid.
This is the first described P. acnes plasmid and this find-
ing could be of importance since the plasmid contained
several virulence-associated genes [30].
Conclusions
The present study provides further evidence for a role of
P. acnes in prostate tumor development by revealing that
men with prostate tumors are more likely to harbor
prostatic P. acnes compared to men without the disease.
Cell-based experiments further indicated that P. acnes
may be a contributing agent by triggering cell prolifera-
tion and IL-6 and IL-8 secretion. If confirmed by pro-
spective studies, these findings could have a profound
impact on prevention and future therapeutic strategies.
Methods
Prostate tissue sampling
Based on estimates of required sample size for identify-
ing an odds ratio (OR) of 1.75 with 80 % power and
25 % exposure prevalence in controls, we included 100
cases and 50 controls in this study. Cases were men di-
agnosed with PCa undergoing consecutive radical pros-
tatectomy procedures and controls were men diagnosed
with bladder cancer undergoing consecutive cystoprosta-
tectomy procedures. During the latter operation the pros-
tate is removed even though no pathological condition is
detected. Because cystoprostectomies are conducted less
frequently, controls required a longer timeframe for re-
cruitment. All surgical procedures were conducted be-
tween January 2009 and March 2015. The mean age of
participants was 64 years (range 53 to 71 years) and
65.7 years (range 42 to 81 years) for cases and controls, re-
spectively. A pathologist examined prostate samples ac-
cording to the same routine procedure as after a radical
prostatectomy and assessed the tissue for PCa without any
histological findings. Controls with histological findings of
prostate tumor were put as a separate group, controls with
PCa. The study was approved by the Ethical Review
Boards in Uppsala-Örebro, Sweden (2008/293). All pa-
tients were informed about the study before giving
written consent.
A biopsy gun and sterile, single-use Biopsy needles (18
ga × 20 cm, ProMagTM Biopsy Needle, Medical Device
Technologies, Gainesville, USA) were used to obtain
multiple cores from both the right and the left lobes of
each prostate. Six biopsies were taken from each pa-
tient’s prostate gland according to the schematic illustra-
tion in Fig. 1. All biopsies were sampled at the operating
theatre immediately after removal of the prostate to
minimize the risk of bacterial contamination. The biop-
sies were placed in tubes containing culture medium
and were immediately transported to the Department of
Laboratory Medicine, Clinical Microbiology, at the
Örebro University Hospital for general cultivation and
further characterization of P. acnes. The laboratory staffs
were blinded to the PCa status of all patients samples.
Culture diagnostics
The culture and species verification of P. acnes was per-
formed in accordance with routine diagnostic proce-
dures. Briefly, the samples were cultured for seven days
in an anaerobic atmosphere (80 % N2, 10 % CO2,
10 % H2) at 37 °C on FAA plates (4.6 % LAB 90 Fastidi-
ous Anaerobe Agar, LAB M, Lancashire, United King-
dom) supplemented with 5 % horse blood. The isolates
were characterized by colony morphology, Gram-
staining, catalase and indole tests. All suspected P. acnes
isolates were further confirmed to species level by API
20 A (bioMérieux, Marcy l’Etoile, France). All isolates
were stored at −70 °C in preservation medium (yeast ex-
tract; Difco Laboratories, Sparks, USA; and horse serum
added to trypticase soy broth [TSB]; BBL, Sparks, MD,
USA) pending further analysis.
Repetitive-sequence-based PCR - DiversiLab
The DNA from the isolates was extracted with the Ultra-
Clean Microbial DNA Isolation kit (bioMérieux) following
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the manufacturer’s instructions. ND-1000 spectrophotom-
eter (NanoDrop Technologies Inc, Wilmington, USA) was
used for DNA quantification and all the samples were ad-
justed to contain approximately 25 to 50 ng/μl. All the
samples were amplified using the DiversiLab Propionibac-
terium Fingerprinting kit (bioMérieux) following the man-
ufacturer’s instructions. Each reaction mixture (25 μl)
contained: 18 μl kit-supplied rep-PCR master mix, 0.5 μl
AmpliTaq polymerase (Applied Biosystems), 2 μl kit-
specific primer mix, 2.5 μl of GeneAmp 10× PCR Buffer,
and 2 μl genomic DNA. The PCRs were performed on a
thermal cycler (GeneAmpPCR System 9700, Applied Bio-
system). The thermal cycling conditions included an initial
pre-incubation at 94 °C for 2 min, and 35 cycles of 94 °C
for 30 s, 60 °C for 30 s, 70 °C for 90 s, and final extension
of 70 °C for 3 min.
To detect the genomic fingerprints of each P. acnes
isolate, the automated microbial genotyping system
(DiversiLab System) was used. The amplified frag-
ments were separated by electrophoresis performed in
microfluidics DNA LabChip and detected with an
Agilent 2100 Bioanalyzer. One CCUG isolate (CCUG
35749) served as positive control in each round of
analysis. The similarity between the isolates was ana-
lyzed by the DiversiLab software, version 3.3.40. In
this version, the Kullback-Leiber method weighs the
presence and absence of peaks rather than peak in-
tensities. The Unweighted Pair Group Method with
Arithmetic mean (UPGMA) was used as a clustering
method and to create dendrograms and scatter plots
[31]. The relatedness was determined by cluster ana-
lysis according to guidelines provided by manufac-
turer. The clustering was defined as a minimum of
95 % similarity, with a difference of up to one band
in the dendrogram.
PCR and sequencing of P. acnes tly gene
The DNA from the isolates was extracted with the
UltraClean Microbial DNA Isolation kit (bioMérieux) fol-
lowing the manufacturer’s instructions. ND-1000 spectro-
photometer (NanoDrop Technologies Inc, Wilmington,
USA) was used for DNA quantification and all the sam-
ples were adjusted to contain approximately 10 ng/μl. The
entire P. acnes tly gene was amplified and sequenced
by using the previously described tly primers PAT-1
(5′-CAGGACGTGATGGCAATGCGA-3′) and PAT-2
(5′TCGTTCACAAGACCACAGTAGC-3′) [25], to
generate a 909 bp amplicon. The PCR was performed
in a real-time LightCycler system (Roche Diagnostics,
Mannheim, Germany) using SYBR Green I fluores-
cence melting curve analysis for detection of specific
amplicon. Each reaction mixture (20 μl) contained:
2 μl Light Cycler FastStart DNA Master SYBR Green
I (Roche Diagnostics), 3 mM MgCl2, 0.5 μM primers
and 2 μl DNA template. The PCR program started
with a pre-incubation at 95 °C for 10 min, followed by
40 cycles of 95 °C for 10 s, annealing at 58 °C for 10 s,
and 72 °C for 37 s.
Prior to sequencing the PCR products were purified
using MultiScreen PCRμ96 plate (Millipore, Molsheim,
France), according to the manufacturer’s instructions.
One microliter of the purified PCR products were then
cycle sequenced using 2 μl Big Dye Terminator v3.1,
according to the manufacturer’s instructions (Applied
Biosystems, Bleiswijk, Netherlands). The cycle sequen-
cing PCR consisted of 25 cycles of 96 °C for 10 s, 58 °C
for 5 s, and 60 °C for 4 min. The nucleotide sequences
were determined by capillary electrophoreses using an
ABI PRISM 3130XL genetic analyzer (Applied Biosys-
tems). The P. acnes tly sequences were aligned and com-
pared to GenBank sequences with accession number
AY527219 (Type IA), AY644408 (Type IB), AY644409
(Type II), and the tly sequence from the reference strain
CCUG 35749 (Type III).
Cell culture
The premalignant prostate epithelial cell line PNT1A
was used. PNT1A cells were cultured in RPMI 1640 sup-
plemented with 10 % foetal bovine serum (FBS) and
2 mM L-glutamine and grown in a 37 °C humid atmos-
phere containing 5 % carbon dioxide.
Short-term infections
Cells were seeded into T75-bottles with a density of 2
million cells/bottle. The cells were allowed to attach to
the flask for 24 h before they were infected with 5, 10,
20, or 50 multiplicity of infection (MOI) of P. acnes type
IA or II. The two P. acnes isolates used were chosen
from the P. acnes collection cultured and genotyped in
this study. Uninfected cells were used as controls. Forty-
eight hours post-infection, the cells were harvested and
the cell media was frozen at −80 °C until further ana-
lyses were performed. The same two P. acnes isolates
were used in all the cell based experiments.
Long-term infections
Cells were seeded into T75-bottles with a density of 2
million cells/bottle. The cells were allowed to attach to
the flask for 24 h before they were infected with 10 MOI
of P. acnes type IA or II. Uninfected cells were used as
controls. Cells were sub-cultured when they reached
80 % confluence and subsequently re-seeded at a density
of 2 million cells/bottle and re-infected with 10 MOI of
P. acnes. One week post the initial infection, cells were
harvested and the cell media was frozen at −80 °C until
further analyses were performed.
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Wound-healing and Proliferation assays
For the wound-healing assays, cells were seeded into
culture inserts (Ibidi, Munchen, Germany) with a density
of 30,000 cells/well and were allowed to attach for 24 h
before 4 μg/ml of Mitomycin C were added to each well.
One hour after the addition of Mitomycin C, the cells
were infected with 5, 10, 20, or 50 MOI of P. acnes type
IA or II. Uninfected cells as well as cells not treated with
Mitomycin C were used as controls. Forty-eight hours
post-infection, the culture inserts were removed and the
cells were allowed to grow for an additional 48 h, before
the closure of the wound was evaluated.
For the proliferation assays, cells were seeded into 96-
well plates at a density of 5000 PNT1A cells/well. The
cells were allowed to attach for 24 h before infected with
5, 10, 20, or 50 MOI of P. acnes type IA or II, uninfected
cells were used as controls. Twenty-four and 48 h post-
infection, cell proliferation was measured using the Cell-
Titer 96® AQueous One Solution Assay from Promega.
The proliferation assays were performed in both tech-
nical and biological triplicates.
Measurement of IL-6 and IL-8 secretion
In order to measure the capability of P. acnes type IA
and II to modulate the secretion of inflammatory media-
tors from prostate cells, excreted IL-6 and IL-8 were
measured by ELISA. The cell media from the short- and
long-term infections was thawed on ice and the samples
were analyzed using IL-6 and IL-8 kits (ELISA MAX
Deluxe Sets, BioLegend, San Diego, USA) according to
the manufacturer’s instructions. The concentration was
determined by measuring the optical density at 450 nm
on a spectrophotometer (Multiskan Ascent, Thermo lab-
systems, Helsinki, Finland). All measurements were per-
formed in three technical replicates.
Statistical analysis
P-values for the univariate association between the pres-
ence of P. acnes and prostate cancer and zonal location
of P. acnes by case–control status were estimated with
Chi-square tests. The independent samples median test
was used to determine if the median number of biopsies
with P. acnes present varied among cases, controls and
controls with PCa. Shapiro-Wilk tests were used to in-
vestigate if the data from in vitro experiments was nor-
mally distributed. Logistic regression was used to
estimate ORs and 95 % confidence intervals for the asso-
ciation between P. acnes and PCa adjusting for age and
smoking status.
The non-parametric Kruskal-Wallis test was used to
determine if there were differences between groups
according to proliferation and secretion. We adjusted
for multiple comparisons with a Bonferroni test, where
p < 0.05 were considered as statistically significant. All
p-values reported from the Kruskal-Wallis tests are after
adjustments for multiple testing. The statistical analyses
were performed in IBM SPSS Statistics version 22 (IBM
Corp. Armonk, NY, USA).
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